P66937 (GYRB_STAAN) Staphylococcus aureus (strain N315)

DNA gyrase subunit B UniProtKBInterProInteractive Modelling

644 aa; Sequence (Fasta) ; 5 identical sequences: Staphylococcus sp. EG-SA-26: A0A9Q2TXU6; Staphylococcus sp. 53017: A0A9P3ZGK3; Staphylococcus aureus: P66936, A0A2Y2JFY9; Staphylococcus aureus subsp. aureus ST228: A0A7U7EWY8

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
1.98A structure of GSK945237 with S.aureus DNA gyrase and singly nicked DNA Heteromer
Q99XG5;
415-640
MN; 10×GOL;CL;6EJ;
Assess
2.31A structure of gepotidacin with S.aureus DNA gyrase and doubly nicked DNA Heteromer
Q99XG5;
415-640
MN;GOL;NA;JHN;
Assess
2.95A structure of Moxifloxacin with S.aureus DNA gyrase and DNA Heteromer
Q99XG5;
414-639
MG;GOL;MFX;
Assess
2.37A structure of gepotidacin with S.aureus DNA gyrase and uncleaved DNA Heteromer
Q99XG5;
416-640
MN;NA;GOL;SO4;JHN;
Assess
2.45A structure of etoposide with S.aureus DNA gyrase and DNA Heteromer
Q99XG5;
417-640
NA;MN;EVP;
Assess
2.5A structure of QPT-1 with S.aureus DNA gyrase and DNA Heteromer
Q99XG5;
416-639
MN;GOL;SO4;NA;54Q;DT;
Assess
2.65 structure of S.aureus DNA gyrase and artificially nicked DNA Heteromer
Q99XG5;
417-640
MN;GOL;
Assess
3.11A complex of S.Aureus gyrase with imidazopyrazinone T3 and DNA Heteromer
Q99XG5;
417-640
MN;NA;GOL;SO4;E3E;
Assess
2.5A structure of GSK945237 with S.aureus DNA gyrase and DNA. Heteromer
Q99XG5;
417-639
MN;GOL;6EJ;
Assess
2.60A BINARY COMPLEX OF S.AUREUS GYRASE with UNCLEAVED DNA Heteromer
Q99XG5;
417-639
GOL;SO4;
Assess
2.8A structure of etoposide with S.aureus DNA gyrase and DNA Heteromer
Q99XG5;
417-639
SO4;MN;GOL;NA;EVP;
Assess
2.8A STRUCTURE OF ZOLIFLODACIN WITH S.AUREUS DNA GYRASE AND DNA Heteromer
Q99XG5;
417-639
GOL;MN;NA;BTB;R8U;
Assess
3.15A structure of QPT-1 with S.aureus DNA gyrase and DNA Heteromer
Q99XG5;
417-638
SO4;NA;GOL;MN;53M;53L;
Assess
3.06A COMPLEX OF S.AUREUS GYRASE with imidazopyrazinone T1 AND DNA Heteromer
Q99XG5;
420-638
MN;SO4;E32;GOL;
Assess
The 2.98A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrasehomo-2-mer411-644
Assess
The 3.1A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrasehomo-2-mer413-644
CA;
Assess
Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomeraseshomo-2-mer416-644
MN;AE8;
Assess
The 3.5A crystal structure of the catalytic core (B'A' region) of Staphylococcus aureus DNA Gyrase …homo-2-mer416-644
RXV;
Assess
Crystal Structure of S. aureus gyrase in complex with 6-[5-[2-[(4-chloro-2,3-dihydro-1H-inden-2-yl)…homo-2-mer417-644
MN;CL;6I0;
Assess
The 2.1A crystal structure of S. aureus Gyrase complex with GSK299423 and DNAhomo-2-mer417-644
MN;RXV;
Assess
Crystal Structure of S. aureus gyrase in complex with 4-[[1-[(1-chloro-6,7-dihydro-5H-cyclopenta[c]…homo-2-mer417-644
MN;CL;ACT;61I;
Assess
The crystal structure of S. aureus Gyrase complex with ID-130 and DNAhomo-2-mer417-644
MN;5UA;DU5;
Assess
The twinned 3.35A structure of S. aureus Gyrase complex with Ciprofloxacin and DNAhomo-2-mer417-644
MN;CPF;
Assess
2.22A STRUCTURE OF THIOPHENE2 AND GSK945237 WITH S.AUREUS DNA GYRASE AND DNAhomo-2-mer416-642
MN;94K;GOL;NA;DMS;6EJ;
Assess
1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNAhomo-2-mer417-642
MN;94H;GOL;CL;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6zt3.1.Amonomer0.734-401
52.78
Assess
6gav.1.Amonomer0.7227-640
54.42
Assess
4i3h.1.Cmonomer0.6827-639
53.38
Assess